Comparison of Gd-EOB-DTPA-enhanced MRI and Contrast-enhanced Ultrasound for Measuring Tumor Size of Solitary Hepatocellular Carcinoma ≤ 5cm:A Retrospective Study

HCC - Hepatocellular Carcinoma Clinical Trial

Official title:
Comparison of CE-MRI and CEUS for Measuring Tumor Size of HCC

Status Completed

Clinical Trial Summary

Knowing the tumor size before operation is of great significance to the choice of treatment methods of surgeons and the prognosis of patients. In this study, two commonly used imaging methods( CE-MRI/CEUS) were selected to measure and compare the tumor size before operation, in order to determine which measurement method is more accurate.

Clinical Trial Description

A total of 194 patients who met the inclusion criteria from January 2019 through May 2024 were included. Taken pathological results as the gold standard, Paired T-test and Bland-Altman analisis were conducted to assess the correlation and mean absolute error between the measured tumor sizes obtained from CE-MRI/CEUS and pathological results. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06437457
Study type	Observational
Source	Anhui Medical University
Contact
Status	Completed
Phase
Start date	January 1, 2019
Completion date	May 20, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04371042` - PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
Not yet recruiting	`NCT05665348` - Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy	Phase 2/Phase 3
Not yet recruiting	`NCT06375317` - HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure	Phase 2